SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-11-054946
Filing Date
2011-11-04
Accepted
2011-11-04 19:23:19
Documents
1
Period of Report
2011-11-02

Document Format Files

Seq Description Document Type Size
1 INITIAL FORM 3 rrd324258.html 3  
1 INITIAL FORM 3 rrd324258.xml 3 2048
  Complete submission text file 0001181431-11-054946.txt   3515
Mailing Address 2530 MERIDIAN PARKWAY 2ND FLOOR DURHAM NC 27713
Business Address 2530 MERIDIAN PARKWAY 2ND FLOOR DURHAM NC 27713 (919) 806-4682
SYNAGEVA BIOPHARMA CORP (Issuer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 667 MADISON AVE 17TH FLOOR NEW YORK NY 10021
Business Address
Biggar Stephen R (Reporting) CIK: 0001340380 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23155 | Film No.: 111182472